Registry Following Adults in Italy Whose Families Carry Pancreatic Cancer Risk
Studies people with inherited higher risk of pancreatic cancer, using scans and endoscopic ultrasound checks.
Plain-language title generated from the registry record
Registry title: Registry of Subjects at Risk of Pancreatic Cancer
Key facts
- Where
- Milan, Peschiera del Garda, Rozzano, and Verona, ItalySee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT04095195, who can take part
Where in Italy
- San Raffele Vita Salute University HospitalMilan, ItalyTaking people
- Ospedale PederzoliPeschiera del Garda, ItalyTaking people
- Istituto Clinico HumanitasRozzano, ItalyTaking people
- Chirurgia Generale e del PancreasVerona, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Associazione Italiana per lo Studio del Pancreas
- Trial code
- NCT04095195
- Record updated
- 13 January 2023
- Original description
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.Read full original descriptionShow less
Italian Registry of Families At Risk of Pancreatic Cancer
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
Inclusion: individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree; subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer; subjects suffering from FAMMM Syndrome; subjects suffering from Peutz-Jeghers Syndrome; subjects suffering from PRSS-1- or CFTR- or SPINK-1- related pancreatitis; subjects suffering from Lynch syndrome with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer; 45 years or 10 years younger than the youngest index case of pancreatic cancer in the family for familial cases; 40 years or 5 years younger than the youngest index case of pancreatic cancer for subjects suffering from hereditary/genetic pancreatitis, Lynch syndrome, or carrying a known BRCA 1/2, PALB2, p16 genetic mutation with familiarity for pancreatic cancer; 30 years for subjects suffering from FAMMM, Peutz-Jeghers syndrome.
Exclusion: pregnancy.